Literature DB >> 15632800

Predictors of antipsychotic medication change.

Michael J Sernyak1, Douglas Leslie, Robert Rosenheck.   

Abstract

Atypical antipsychotics account for more than 60% of antipsychotic prescriptions written for the treatment of schizophrenia. While switching from one antipsychotic to another is a dynamic process, there has been no research on individual patient and institutional characteristics that predict antipsychotic switching. VA national administrative data were used to identify patients (n = 9660) with schizophrenia maintained on antipsychotic medication. Logistic regression was used to identify predictors of medication switching. Independent variables included information about service utilization, sociodemographic and clinical variables as well as institutional characteristics. This model was repeated for more specific switches between classes of medications and between specific medications. High levels of outpatient and inpatient service use were the most powerful predictors of switching. Sociodemographic, institutional, diagnostic, and functional measures were also predictive in some cases. Controlling for independent sociodemographic, diagnostic, and functional measures, frequency of clinical contact was the most robust predictor of switching antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632800     DOI: 10.1007/BF02287330

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  8 in total

1.  Delays in adopting evidence-based dosages of conventional antipsychotics.

Authors:  M Valenstein; L Copeland; R Owen; F Blow; S Visnic
Journal:  Psychiatr Serv       Date:  2001-09       Impact factor: 3.084

2.  Best practices: racial and ethnic effects on antipsychotic prescribing practices in a community mental health center.

Authors:  Scott W Woods; Michelle C Sullivan; Elizabeth C Neuse; Esperanza Diaz; C Bruce Baker; Steven H Madonick; Ezra E H Griffith; Jeanne L Steiner
Journal:  Psychiatr Serv       Date:  2003-02       Impact factor: 3.084

3.  The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.

Authors:  D L Leslie; R Rosenheck
Journal:  J Nerv Ment Dis       Date:  2001-06       Impact factor: 2.254

4.  Access to public mental health services: determinants of population coverage.

Authors:  R Rosenheck; M Stolar
Journal:  Med Care       Date:  1998-04       Impact factor: 2.983

5.  A novel augmentation strategy for treating resistant major depression.

Authors:  R C Shelton; G D Tollefson; M Tohen; S Stahl; K S Gannon; T G Jacobs; W R Buras; F P Bymaster; W Zhang; K A Spencer; P D Feldman; H Y Meltzer
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

6.  The efficacy and safety of risperidone for the treatment of geriatric psychosis.

Authors:  J P Hwang; C H Yang; H C Yu; J W Chang; C Y Cheng; S J Tsai
Journal:  J Clin Psychopharmacol       Date:  2001-12       Impact factor: 3.153

7.  From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.

Authors:  Douglas L Leslie; Robert A Rosenheck
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

8.  Combination antipsychotic therapy in clinical practice.

Authors:  Andre Tapp; Amanda Ernst Wood; Lori Secrest; Jaime Erdmann; Lindy Cubberley; Nael Kilzieh
Journal:  Psychiatr Serv       Date:  2003-01       Impact factor: 3.084

  8 in total
  2 in total

1.  Predictors of switching antipsychotic medications in the treatment of schizophrenia.

Authors:  Allen W Nyhuis; Douglas E Faries; Haya Ascher-Svanum; Virginia L Stauffer; Bruce J Kinon
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

2.  Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study.

Authors:  Giammarco Cascino; Rossella Ceres; Alessio Maria Monteleone; Paola Bucci; Giulia Maria Giordano; Silvana Galderisi; Palmiero Monteleone
Journal:  J Clin Med       Date:  2022-10-10       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.